Severine Bompoint- Senior Statistical Programmer

Severine is a Senior Statistical Programmer at The George Institute. Severine has a Bachelor degree in Computer Science, Information Systems and Piloting and an Associate Degree in Statistics and Data Management from the University of South-Brittany, France.

Before joining the George Institute in 2006 she worked in a contract research organisation in the United States and at the National Research and Safety Institute in France. She has extensive experience programming and validating statistical analyses for clinical trials from various phases and therapeutic areas including immunology, oncology and cardiology.


How long have you been working at The George Institute?
9 years

What attracted you to working at The George Institute?
I have always found the mission of The George Institute very appealing. But on a day-to day basis, it is the combination of academic and commercial work on such a big variety of therapeutic areas that keeps me interested.

What is your professional background?
I started as a SAS programmer at Statistics Collaborative in Washington DC in 2001, moved to Australia in late 2005 and joined the George Institute.

Why do you enjoy working at The George Institute?
I consider myself very lucky to be surrounded by so many nice and talented individuals. We have a very strong a friendly statistics team, and I truly appreciate the flexibility that allows me to work part-time.

What are you currently working on?
I just started collaborating with the food policy team on their salt studies, as well as working on the TEXT-ME cardiovascular trial and the Active Dialysis renal project.

What is a recent highlight?
Seeing the results of the PACE trial after doing the main analysis on the front page of The Times in the UK was quite an achievement.

What difference will this make to healthcare and why?
Low-back pain is the leading cause of disability worldwide and this study shows that improved focus on development of new, effective treatments is warranted.

What is your biggest achievement so far?
I worked for three years full-time on the ADVANCE study, the largest clinical trial in diabetes. We had a great team, and being present in Vienna when the results were presented in front of an audience of more than five thousands was incredible.